Individuals with severe deficiency, high physical demands, illness recovery needs, or chronic fatigue should choose a B12 IV infusion over a shot
Unlike many peptides that degrade quickly in the digestive system, BPC-157 demonstrates remarkable stability and bioavailability, making it effective through multiple administration routes including oral, subcutaneous, and intramuscular delivery
2.5 mg dose in a 12 mg vial: Target 50 units (0.5 mL)
(3) The peptide has been researched for its potential action across diverse functions, including tissue repair, pain perception, gastrointestinal regulation, and tendon, ligament, muscle, and bone cell reparations
Here is what we see in the first, second, and third month of a typical protocol, based on the indications above
No, its the standard and recommended diluent for most research peptides intended for multi-use